0000899866-17-000057.txt : 20170301
0000899866-17-000057.hdr.sgml : 20170301
20170301194528
ACCESSION NUMBER: 0000899866-17-000057
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170227
FILED AS OF DATE: 20170301
DATE AS OF CHANGE: 20170301
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ALEXION PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0000899866
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 133648318
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 100 COLLEGE STREET
CITY: NEW HAVEN
STATE: CT
ZIP: 06510
BUSINESS PHONE: 2032722596
MAIL ADDRESS:
STREET 1: 100 COLLEGE STREET
CITY: NEW HAVEN
STATE: CT
ZIP: 06510
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: MACKAY MARTIN
CENTRAL INDEX KEY: 0001414815
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-27756
FILM NUMBER: 17656487
MAIL ADDRESS:
STREET 1: PFIZER INC ATTN CORPORATE SECRETARY
STREET 2: 235 EAST 42ND STREET
CITY: NEW YORK
STATE: NY
ZIP: 10017
4
1
wf-form4_148841551440469.xml
FORM 4
X0306
4
2017-02-27
0
0000899866
ALEXION PHARMACEUTICALS INC
ALXN
0001414815
MACKAY MARTIN
C/O ALEXION PHARMACEUTICALS, INC
100 COLLEGE STREET
NEW HAVEN
CT
06510
0
1
0
0
EVP & Global Head of R&D
Common Stock, par value $.0001 per share
2017-02-27
4
S
0
860
131.20
D
38883
D
Common Stock, par value $.0001 per share
2017-02-28
4
S
0
625
131.70
D
38258
D
Common Stock, par value $.0001 per share
2017-02-28
4
A
0
12800
0
A
51058
D
Common Stock, par value $.0001 per share
2017-03-01
4
S
0
370
132.50
D
50688
D
Option to Purchase Common Stock
131.25
2017-02-28
4
A
0
12800
0
A
2018-02-28
2027-02-28
Common Stock, par value $.0001 per share
12800.0
12800
D
This sale was made to cover withholding taxes immediately following the vesting of previously granted Restricted Stock Units.
This transaction was executed in multiple trades through a broker-dealer at prices ranging from $131.00 - $131.99. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares sold at each price.
Award of Restricted Stock Units under the 2004 Incentive Plan. 25% vests on each anniversary of the grant date.
This transaction was executed in multiple trades through a broker-dealer at prices ranging from $132.00 - $132.99. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares sold at each price.
Stock option award under 2004 Incentive Plan. 25% vest on the first anniversary of the grant date, 1/16 every three months thereafter until fully vested over 4 years.
/s/ Michael Greco, Attorney-in-Fact for Martin Mackay
2017-03-01